The Deep Sedation for Ablation Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03844841

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03844841
Other papers using this trial's data
  • Electrophysiological differences of randomized deep sedation with dexmedetomidine versus propofol BMC anesthesiology, 2024-07-31 DOI, PubMed 39085782, PMC11290000 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03844841. Randomized; single masking; primary purpose treatment. Start 2019-07-01 (actual); primary completion 2020-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Deep Sedation for Ablation Study
Condition
Ablation
Condition
Sedation
Condition
Propofol
Condition
Dexmedetomidine
Intervention (Drug)
Propofol
Intervention (Drug)
Dexmedetomidine
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct03844841
Content hash
c94ea889756b454baadcf0a441025fa86a66dd76a0a0cb249ae5938728898908